Navigation Links
The Global Drug Eluting & Bare Metal Coronary Stents Market is Booming: Expected to Attain a Market Size of USD 8.3 Billion by 2016

NEW YORK, November 22, 2011 /PRNewswire/ --

According to a new report published by Transparency Market Research ( "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)"Global Coronary Stents market is estimated to be USD 6,013million in 2011 and expected to reach USD 8,292million in 2016 at a CAGR of 6.6% over the period 2010 to 2016. The Drug Eluting Stents (DES) segment is the leading market contributor with a share of around 55% - 60% in 2010.

Browse full report at 

With the high prevalence of cardiovascular diseases, the global coronary stent market is gaining every year experiencing a 6.6% CAGR growth. Also, owing the growth in demand for minimally invasive procedures, these stents, especially drug eluting stents, are finding rapid increase in their market penetration of more than 60% approximately.

The drug eluting stents (DES) segment contributed 55%-60% of the global coronary stent market in 2010. The global DES segment is expected to reach USD 5.3 billion in 2016 after growing at a CAGR of 9.54% from 2011 to 2016.The biggest factor in the growth of this market is found in the aging populations in developed countries. Segmented by geographic regions, the market for Drug Eluting Stents (DES) is growing at 9.0% in the United States, at 3.1% in Europe, at 10% in Asia-Pacific and 3.1% in the rest of the world. At present, the strongest area of growth is drug eluting stents - after the introduction of which the growth in bare-metal stents declined quickly.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

The market for bare-metal stents (BMS) segment globally contributed around 40% to 45% of the global coronary stent market in 2010 and is expected to reach at a market size of USD 2.9 billion by 2016 growing at a rate of 2% CAGR during 2011 and 2016.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

Among the various markets across the globe, the U.S forms the largest market for Coronary stents followed by Europe, the Asia-Pacific region countries, Japan and China.The leading players in this market include Johnson & Johnson, Boston Scientific, Abbott Laboratories and Medtronics making up for the major share of the market worldwide.

Scope and Overview

The report covers all the major types of coronary stents - i.e. Drug Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The report discusses the key influencing factors for the coronary stent market across the geographies. The report also includes an in-depth analysis of different sub-segments. The report estimates, forecasts the market sizes (2010-2016) and growth rates for different segments and geographies. The report analyses the global trend of coronary stent market and discusses the rationale behind various industry moves. The report provides competitive scenario of this market and highlights major market going-on.An in-depth geographic analysis is conducted for each of the sub-segment in the major regional markets of Americas, Europe, Asia and ROW.The report also covers the strategies followed by "Global Drug Eluting, Bare-Metal and Other Coronary Stents Market" players.

Segmentation & Analysis

The report segments and analyzes the "Global Drug Eluting,Bare-Metal and Other Coronary Stents Market" on the basis of following sub-categories:

  • Major Geographic Markets
    • North America
    • Europe
    • Asia - Pacific
    • ROW

This section provides in-depth analysis of "Global Drug Eluting, Bare-Metal and Other Coronary Stents Market" that includes market size and growth forecast for each geography and opportunities prevailing in the particular geography.

  • Coronary Stents Segments
    • Drug Eluting Stents (DES)
    • Bare-Metal Stents (BMS)
    • Absorbable Stents
    • Bioactive Stents

This section provides in-depth analysis of Coronary Stents market size and growth forecast for each sub segment, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.

  • Competitive Landscape &Trends analysis

This section presents technology-strategy mapping and emerging trends in the coronary .stents market development with analysis of in-market case.

  • Product Pipeline Analysis

This section analyses the new product developments, clinical trials for coronary stents and their impact on the market.

  • Company Profiles of Top Players

This section provides brief overview of top market players in the "Global Drug Eluting, Bare-Metal and OtherCoronary Stents Market". The profile of each company includes brief overview, key financials, product & services, recent developments and key strategies adopted by the player.

Browse all Medical Devices Market Research Reports

Pre book our upcoming report on

NanoSilver Market 

Vaccine Market 

Organic Electronics Market

Carbon Capturing Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Ms Amita
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Market Research Blog
Market Research Blog

SOURCE Transparency Market Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
2. Global Diagnostic Imaging Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
3. X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Medical Robotics and Computer-Assisted Surgery: The Global Market
5. MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
6. Global Pharm Holdings Group, Inc. Announces Third Quarter 2011 Financial Results
7. Drugs for Treating Congestive Heart Failure: Global Markets
8. Global Markets for Marine-Derived Pharmaceuticals
9. Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
10. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
11. Ceramic Fiber Market by Type, Applications and Global Forecasts (2011-2016)
Post Your Comments:
(Date:11/30/2015)... Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... December 3, 2015. TIME: 3:15p.m. ET LINK: ... --> DATE: Thursday, December ... --> --> This will ... to ask the company questions in real-time - both in ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
Breaking Medicine Technology:
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone will experience ... friend, or animal pass away, death lives among us. It is your perspective, however, ... a family of 11 children, author T Sky understands that she may see death ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case ... from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health ...
(Date:11/30/2015)... , ... November 30, 2015 , ... The successful filing ... pharmaceutical company. Because it is so important to this key industry segment, Regis Technologies ... your IND Filing” on December 4th at 11am EST. , Federal law does not ...
Breaking Medicine News(10 mins):